Data is not available at this time.
YLZ Information Technology Co., Ltd operates as a specialized software and information services provider focused on China's critical livelihood industries. The company's core revenue model centers on developing and implementing comprehensive IT solutions for sectors including medical insurance, healthcare, human resources, and intelligent IoT systems. By targeting essential public service domains, YLZ occupies a niche position within China's broader technology ecosystem, serving government agencies and institutional clients that require robust data management and digital transformation capabilities. The company leverages its big data innovation expertise to create integrated platforms that address complex administrative and operational challenges in these regulated industries. Founded in 2000 and headquartered in Xiamen, YLZ has established long-term relationships with public sector entities, positioning itself as a trusted technology partner for modernization initiatives. This focus on mission-critical systems provides some insulation from purely commercial market cycles but creates dependency on government budgeting and policy priorities. The company's market position reflects its deep domain expertise in specific verticals rather than broad horizontal software applications.
YLZ generated revenue of CNY 558.4 million for the period but reported a net loss of CNY 43.3 million, indicating significant profitability challenges. The negative operating cash flow of CNY 34.4 million, despite relatively modest capital expenditures of CNY 1.3 million, suggests operational inefficiencies or timing differences in cash collection. The diluted EPS of -0.1 reflects the company's current unprofitability on a per-share basis, highlighting fundamental business model pressures that require strategic attention.
The company's earnings power appears constrained, with negative net income and operating cash flow indicating an inability to convert revenue into sustainable profits. The modest capital expenditure level suggests limited investment in growth assets, potentially reflecting cautious capital allocation amid challenging operating conditions. The negative cash generation raises questions about the scalability of current operations and the efficiency of invested capital in creating shareholder value.
YLZ maintains a relatively strong liquidity position with cash and equivalents of CNY 350.7 million, providing a buffer against current operational losses. The minimal total debt of CNY 11.8 million indicates a conservative leverage profile, with the company operating with essentially a net cash position. This financial structure provides flexibility but also suggests underutilization of potential growth capital given the company's current market capitalization.
The current financial performance does not indicate positive growth momentum, with the company experiencing losses during the period. The absence of a dividend payment aligns with the unprofitable status and negative cash flow generation. Future growth prospects likely depend on the company's ability to stabilize operations and achieve sustainable profitability before considering capital return to shareholders.
With a market capitalization of approximately CNY 2.9 billion, the market appears to be valuing YLZ at a significant premium to its current financial performance, suggesting expectations of future recovery or growth. The low beta of 0.307 indicates relatively low correlation with broader market movements, potentially reflecting the company's niche positioning and specific risk factors unique to its government-focused business model.
YLZ's primary strategic advantage lies in its specialized domain expertise within China's livelihood industries, particularly medical insurance and healthcare IT. However, the current financial performance indicates significant operational challenges that must be addressed. The outlook depends on the company's ability to leverage its government relationships and technical capabilities to achieve sustainable profitability while navigating the specific demand cycles and procurement patterns of its public sector client base.
Company filingsFinancial data providers
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |